Previous slide Next slide New Generation Biotechnology Based on Gut DNA Test and patented probiotics, We target personalised supplementation to improve various health issues.https://biomed.hk/wp-content/uploads/2023/10/未命名設計-2-1-1.mp4 Gut Microbiota DNA Test 16S rRNA Test and Real-time Fluorescent quantitative PCR Technology to detect several specific species of bacteria. After data analysis, the risk of intestinal health and
Location: China, Hong Kong Island, Hong Kong
Employees: 201-500
Investors 1
| Date | Name | Website |
| - | Gobi Partn... | gobi.vc |
Mentions in press and media 3
| Date | Title | Description | Source |
| 26.06.2023 | Strategic Investment in BioMed by Human Health for Propellin... | HONG KONG SAR – Media OutReach – 26 June 2023 – In celebration of the World Microbiome Day on 27th J... | africanews... |
| 20.04.2023 | BioMed Technology Funded by Alibaba Hong Kong Entrepreneurs ... | HONG KONG, April 20, 2023 /PRNewswire/ -- BioMed Technology Holdings Limited (BioMed), Hong Kong's l... | en.prnasia... |
| - | BioMed Technology Holdings | “BioMed develops a personalized intestinal treatment plan with probiotics, a series of probiotic pro... | fastfounde... |